Moderna has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use ...

The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Moderna slumped to a far bigger quarterly loss than expected and delivered a disappointing sales forecast, sending shares in the Covid-19 vaccine maker down as much as 18 per cent.

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children.

Demand for the jab through the NHS and privately in pharmacies has remained steady since the end of the pandemic ...

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the US, alleging they copied technology that Moderna ...

The Moderna study enrolled 3,732 teens aged 12 to 17, and found there were no cases of symptomatic Covid-19 in those who had the vaccine. Advertisement Close ...

The first "tweaked" vaccine against the worrying coronavirus variants that emerged in South Africa and Brazil has successfully neutralised them in laboratory trials, the US company Moderna has ...

Iceland has suspended administering the Moderna Covid-19 vaccine citing the slight increased risks of cardiac inflammation, going further than its Nordic neighbours which have simply limited use ...

Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children with medical conditions that put them at higher risk of severe illness.